Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 07, 2023

BUY
$30.46 - $46.04 $122,114 - $184,574
4,009 Added 41.93%
13,570 $413,000
Q2 2023

Aug 02, 2023

SELL
$31.57 - $37.73 $161,291 - $192,762
-5,109 Reduced 34.83%
9,561 $357,000
Q1 2023

May 10, 2023

BUY
$29.72 - $41.45 $166,283 - $231,912
5,595 Added 61.65%
14,670 $468,000
Q4 2022

Feb 07, 2023

BUY
$30.23 - $38.71 $274,337 - $351,293
9,075 New
9,075 $323,000
Q2 2022

Aug 08, 2022

SELL
$20.97 - $37.47 $219,723 - $392,610
-10,478 Closed
0 $0
Q1 2022

May 12, 2022

BUY
$34.38 - $65.77 $360,233 - $689,138
10,478 New
10,478 $387,000

Others Institutions Holding INMD

About InMode Ltd.


  • Ticker INMD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 83,081,104
  • Market Cap $1.49B
  • Description
  • InMode Ltd. designs, develops, manufactures, and markets minimally invasive aesthetic medical products based on its proprietary radiofrequency assisted lipolysis and deep subdermal fractional radiofrequency technologies in the United States and internationally. The company offers minimally invasive aesthetic medical products for various procedur...
More about INMD
Track This Portfolio

Track Oppenheimer & CO Inc Portfolio

Follow Oppenheimer & CO Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Oppenheimer & CO Inc, based on Form 13F filings with the SEC.

News

Stay updated on Oppenheimer & CO Inc with notifications on news.